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Oxidants are produced in physiological and pathological
conditions. The production of reactive nitrogen and oxygen
species (RNS and ROS, respectively) can lead to vastly differ-
ent cellular outcomes depending on their subcellular loca-
tion, half-life, reactivity, gradients, and the antioxidant
defenses. While oxidative stress caused by general oxidative
damage is often nonspecific and linked to cell death by necro-
sis, at lower concentrations, ROS and RNS can act as second
messengers regulating redox-sensitive signaling pathways,
which elicit very specific cellular responses [1, 2]. Redox sig-
naling is an intrinsic, tightly regulated component of cell
metabolism, controlling cell growth, differentiation, and
death. The interplay between the production of oxidants
and the antioxidant defenses is highly regulated to maintain
cellular redox homeostasis [3, 4]; thus, its dysregulation
underlies many pathological conditions, including cancer,
neurodegeneration, and cardiovascular and metabolic dis-
eases. This special issue is focused on redox signaling in
pathology and developments in redox-based therapies.
In this issue, H. Pérez et al. examined the molecular basis
of the role of p66Shc in brain mitochondrial dysfunction,
showing a connection with ROS/RNS production, Sirt 3
activity modulation, and mitochondrial dynamics and bio-
genesis. The modulation of p66shc activity could be a candi-
date for therapeutic intervention for longer lifespan or higher
quality of life. In an article exploring the stimulatory role of
nitric oxide (NO) on protein synthesis in the muscle, R.
Wang et al. show that protein synthesis is regulated in a
NO-dependent manner in differentiated C2C12 myoblasts
by the mTOR/p70S6K pathway, highlighting the potential
clinical applications of targeting the production of NO in
muscle metabolism. Also, by a thorough examination of
heart function and metabolites in a mouse Nrf2 knock-out
model, R. Erkens et al. show that inhibition of NO synthesis
at the onset of ischemia (I) and during early reperfusion (R)
worsened myocardial damage and systolic dysfunction in
Nrf2-deficient animals. The study reveals that eNOS upregu-
lation under conditions of compromised antioxidant capacity
may afford cardioprotection against I/R. K. Xu et al. discuss
tryptophan and its metabolites as a source of antioxidant
defense in theplacenta. The authors summarize data onmech-
anisms that involve tryptophan and 3-hydroxyanthranilic
acid, a metabolite of the tryptophan-kynurenine pathway,
as initiators of signaling events that activate Nrf2 in the pla-
centa, stimulating the expression of antioxidant proteins
and proteins responsible for the biosynthesis of low molecu-
lar weight antioxidants.
In relation to cancer, S. V. Kostyuk et al. examined the
penetration of easily oxidizable GC-rich DNA fragments
(GC-DNA) into breast cancer cells and their potential for
therapeutic development. Results from the study indicate
that GC-DNA provided in the cell culture medium inter-
acts with the cell surface, induces NOX4 expression, and
undergoes oxidation by augmentation of reactive oxygen
production. Thus, the incorporation and expression of
cell-free DNA in cancer cells may harbor utility for thera-
peutic development.
Additional articles in this special issue address funda-
mental aspects of redox signaling in physiological conditions.
P. V. Avdonin et al. uncovered that H2O2 synergizes with
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calcium-mobilizing agonists of the 5-hydroxytryptamine
receptors 5-HT1B and 5-HT2B through the induction of
endogenous oxidative stress in human umbilical vein endo-
thelial cells and suggested that H2O2 potentiation of agonist-
induced calcium signaling in endothelial cells may contribute
to vasorelaxation. In another study by C. Urbainsky et al.,
the authors performed a comprehensive analysis of the sub-
strates and functions of the oxidoreductase nucleoredoxin
(Nrx) in neuronal cells. Their results suggest that Nrx may
be involved in the redox regulation of cell morphology
and metabolism.
Four review articles cover current knowledge of the role of
oxidants and redox signaling in pathology. S. Boukhenouna
et al. discuss the biological role of reactive oxygen species
in the progression of chronic obstructive pulmonary disease
(COPD) and cellular mechanisms to repair oxidative dam-
age. A primary factor in the development of COPD is expo-
sure to cigarette smoke that induces oxidative stress and
epithelial cell damage. Cigarette smoke is the leading risk
factor of lung injury and pulmonary emphysema. Sustained
oxidative damage to biomolecules forces chronic upregula-
tion of antioxidant and other cytoprotective responses.
Under the high oxidative stress conditions documented in
patients with COPD, defense systems can reach exhaustion
failing to halt further disease deterioration. E. Richard et al.
summarize the current knowledge on the pathophysiological
role of reactive oxygen species and redox imbalance in
inborn errors of metabolism (IEM), with a focus on selected
branched-chain amino acid disorders, organic acidurias, and
homocystinuria. The authors also cover the source of ROS in
these IEMs and evaluate the efficacy of antioxidant therapies
and mitochondria-targeted approaches in these diseases.
Also, A. Giuffrè and J. B. Vicente present a comprehensive
review of the biochemistry of hydrogen sulfide and its intri-
cate interactions with other gasotransmitters. The work
covers hydrogen sulfide occurrence in biological fluids and
tissues, biogenesis and catabolism by specialized enzymes,
partition in intra- and extracellular compartments, signaling,
abnormal homeostasis in cardiovascular disease, neurode-
generative disorders and cancer, and reactivity with NO
and CO. The review by R. Manoharan et al. describes the
role of serine-threonine kinase receptor-associated protein
(STRAP) in the regulation of cell proliferation and death
in normal and cancer cells. While STRAP interacts with
many redox-sensitive proteins to promote cell survival and
proliferation in both normal and cancer cells, under condi-
tions that affect the redox balance, STRAP may also induce
cell death. This dual role of STRAP in cancer cells may
uncover novel therapeutic options for cancer treatment.
Therapeutic strategies aimed at restoring redox homeo-
stasis have been pursued for many years, albeit with very
limited success. In this special issue, N. E. Buglak et al. pres-
ent a critical review of the literature, evaluating successful
and unsuccessful approaches, including patient selection,
dose, and delivery route. The authors also focus on the
development of local targeted delivery of antioxidants as
a promising therapeutic approach to address local redox
dysfunction. For example, J. Paprocki et al. study how dif-
ferent markers of the oxidant-antioxidant equilibrium are
modulated after repeated stimulation with hyperbaric oxygen
(HBO), a therapy associated with increased production of
reactive oxygen species used to treat sudden sensorineural
hearing loss. Another example is the use of cold physical
plasma (CAP), a therapeutic strategy that generates reactive
oxygen and nitrogen species, used for chronic and acute
wound treatment. In this issue, A. Schmidt et al. show that
CAP activates a complex cellular response and discuss the
functional consequences of the clinical use of plasmas for
wound treatment.
The lack of tools to isolate specific oxidative modifica-
tions has hindered our understanding of the functional con-
sequences of such modifications for many years. Here, J. J.
Porter and R. A. Mehl summarize current knowledge of oxi-
dative posttranslational protein modifications and the devel-
opment of new tools through genetic code expansion, for the
genetically encoded, site-specific incorporation of amino
acids carrying oxidative modifications into proteins. These
tools enable the accurate determination of the role of a partic-
ular posttranslational modification at unique positions in a
protein of choice.
In summary, this special issue highlights the importance
of understanding the molecular basis of redox signaling and
the need for targeted therapies that have so far remained a
major challenge in the field.
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